Clinical Trial Clinical Trial
— FCU4HealthOfficial title:
An Individually Tailored, Family-Centered Intervention for Childhood Obesity: Connecting Services in Pediatric Primary Healthcare, the Home and the Community
Verified date | May 2023 |
Source | Arizona State University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study is a hybrid implementation-effectiveness trial of the Family Check-Up 4 Health (FCU4Health), an adapted version of the Family Check-Up, in pediatric primary care. Patients will be recruited based on their BMI as documented in the Electronic Health Record (EHR) and randomized to receive the FCU4Health or Treatment as Usual.
Status | Active, not recruiting |
Enrollment | 240 |
Est. completion date | June 30, 2024 |
Est. primary completion date | December 30, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 6 Years to 12 Years |
Eligibility | Inclusion Criteria: - BMI at or above 85% tile for age and gender Exclusion Criteria: - |
Country | Name | City | State |
---|---|---|---|
United States | Phoenix Children's Hospital | Phoenix | Arizona |
United States | Terros Health | Phoenix | Arizona |
United States | Valle del Sol | Phoenix | Arizona |
Lead Sponsor | Collaborator |
---|---|
Arizona State University | Northwestern University, University of Southern California, University of Washington |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | BMI | BMI | The investigators will examine trajectories based on 4 assessments over one year | |
Secondary | Body Composition | % Body fat | The investigators will examine trajectories based on 4 assessments over one year | |
Secondary | EuroQol-5D-5Level-Youth (EQ-5D-5L-Y) | Quality of life | The investigators will examine trajectories based on 4 assessments over one year | |
Secondary | PedsQL | Quality of life | The investigators will examine trajectories based on 4 assessments over one year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04395430 -
A Novel School-clinic-community Online Model of Child Obesity Treatment in Singapore During COVID-19
|
N/A | |
Completed |
NCT03250715 -
Effects of Low Level Laser Therapy on Functional Capacity and DNA Damage of Patients With Chronic Kidney Failure
|
N/A | |
Completed |
NCT03501225 -
Effects of Ozonated Water on Pain, Swelling, Trismus and Quality of Life in Third Molar Surgery
|
N/A | |
Terminated |
NCT03308435 -
Effect of TF-TAVR on Emotional Status, Quality of Life, Frailty and Inflammation
|
||
Recruiting |
NCT03864250 -
Tacrolimus Monotherapy for Idiopathic Membranous Nephropathy
|
N/A | |
Completed |
NCT03351283 -
Effect of Sodium Intake on Brain Natriuretic Peptide Levels in Patients With Heart Failure
|
N/A | |
Completed |
NCT03757767 -
The Fasting Study - Unraveling the Mechanistic Effects of Prolonged Fasting in Humans.
|
N/A | |
Recruiting |
NCT05712616 -
Role of Strontium Ranelate in Proximal Femur Fragility Fractures.
|
Phase 4 | |
Completed |
NCT03189511 -
Effect of Fluvastatin on Brown Fat Activity
|
Phase 4 | |
Recruiting |
NCT03788876 -
Neuromuscular Electrical Stimulation After Lung Transplantation
|
N/A | |
Completed |
NCT05622760 -
Impact of the Different Information Channels in Reducing Anxiety in Participants of Cervical Cancer Screening
|
N/A | |
Enrolling by invitation |
NCT04469816 -
AFRI Childhood Obesity Prevention Challenge Area
|
N/A | |
Completed |
NCT04958460 -
Effect of Probiotics on ADHD
|
Phase 3 | |
Completed |
NCT03124316 -
Testing a Behavioural Approach to Improving Cancer Screening Rates
|
N/A | |
Recruiting |
NCT06037603 -
Dual-Task Exercise for Mild Traumatic Brain Injury (mTBI)
|
N/A | |
Completed |
NCT03037476 -
Personalized Health Assessment Related to Medications (Project PHARM)
|
N/A | |
Completed |
NCT01149278 -
Assessment of Two Levels of Arterial Pressure on Survival in Patients With Septic Shock
|
N/A | |
Completed |
NCT05012709 -
A Study of Dose-response Relationship and the Evidence Based Multisensory Stimulation Intervention
|
N/A | |
Recruiting |
NCT04719221 -
Impact of Evolocumab as an Additional Lipid-lowering Therapy to Changes in Lipid Core Burden Index of Non-culprit Vulnerable Plaque in Patients Who Underwent Percutaneous Coronary Intervention for the Acute Coronary Syndrome
|
Phase 4 | |
Completed |
NCT04896099 -
Feasibility of Supportive Care Needs in Patients With Advanced Solid Cancer in a Therapeutic Trial
|